Loading company…
TME Therapeutics develops cell production technology for cultured meat and stem cell research.
Founded in 2020 in Incheon, South Korea, TME Therapeutics develops cell growth and control technology for cultured meat production. It also provides coated surfaces that support the expansion of stem cells, including mesenchymal, satellite, and neural stem cells. The company raised KRW 500 million in seed funding in March 2023 from Korea Tech Incubator for Startup, with Big Bang Angels participating. Funding was intended to develop cultured meat processes and reduce production costs.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in